ATE329018T1 - Verbesserte galactosylierung von rekombinanten proteinen - Google Patents
Verbesserte galactosylierung von rekombinanten proteinenInfo
- Publication number
- ATE329018T1 ATE329018T1 AT01907078T AT01907078T ATE329018T1 AT E329018 T1 ATE329018 T1 AT E329018T1 AT 01907078 T AT01907078 T AT 01907078T AT 01907078 T AT01907078 T AT 01907078T AT E329018 T1 ATE329018 T1 AT E329018T1
- Authority
- AT
- Austria
- Prior art keywords
- recombinant proteins
- galactosylation
- improved
- improved galactosylation
- enhanced
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/005—Glycopeptides, glycoproteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US18110800P | 2000-02-08 | 2000-02-08 | |
| US19164100P | 2000-03-23 | 2000-03-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE329018T1 true ATE329018T1 (de) | 2006-06-15 |
Family
ID=26876894
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01907078T ATE329018T1 (de) | 2000-02-08 | 2001-02-07 | Verbesserte galactosylierung von rekombinanten proteinen |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US20030211573A1 (de) |
| EP (1) | EP1254216B1 (de) |
| JP (1) | JP2003521942A (de) |
| AT (1) | ATE329018T1 (de) |
| AU (1) | AU783973B2 (de) |
| CA (1) | CA2399266A1 (de) |
| DE (1) | DE60120356T2 (de) |
| ES (1) | ES2266159T3 (de) |
| IL (1) | IL151131A0 (de) |
| WO (1) | WO2001059089A2 (de) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI328614B (en) | 2002-12-23 | 2010-08-11 | Bristol Myers Squibb Co | Product quality enhancement in mammalian cell culture processes for protein production |
| KR101351122B1 (ko) * | 2003-05-09 | 2014-01-14 | 듀크 유니버시티 | Cd20-특이적 항체 및 이를 이용한 방법 |
| TW201516149A (zh) | 2006-09-13 | 2015-05-01 | Abbvie Inc | 細胞培養改良 |
| US8911964B2 (en) | 2006-09-13 | 2014-12-16 | Abbvie Inc. | Fed-batch method of making human anti-TNF-alpha antibody |
| US7873748B2 (en) * | 2007-11-30 | 2011-01-18 | International Business Machines Corporation | Synchronization of locally and remotely stored browser data |
| CA2932207A1 (en) * | 2008-10-20 | 2010-12-09 | Abbvie Inc. | Isolation and purification of antibodies using protein a affinity chromatography |
| CN104974251A (zh) | 2008-10-20 | 2015-10-14 | Abbvie公司 | 在抗体纯化过程中的病毒灭活 |
| US20120329709A1 (en) * | 2009-05-26 | 2012-12-27 | Brian Edward Collins | Production of glycoproteins |
| AU2011237442A1 (en) | 2010-04-07 | 2012-10-18 | Momenta Pharmaceuticals, Inc. | High mannose glycans |
| WO2012125553A2 (en) | 2011-03-12 | 2012-09-20 | Momenta Pharmaceuticals, Inc. | N-acetylhexosamine-containing n-glycans in glycoprotein products |
| WO2012149197A2 (en) | 2011-04-27 | 2012-11-01 | Abbott Laboratories | Methods for controlling the galactosylation profile of recombinantly-expressed proteins |
| US9181572B2 (en) | 2012-04-20 | 2015-11-10 | Abbvie, Inc. | Methods to modulate lysine variant distribution |
| US9067990B2 (en) | 2013-03-14 | 2015-06-30 | Abbvie, Inc. | Protein purification using displacement chromatography |
| US9150645B2 (en) | 2012-04-20 | 2015-10-06 | Abbvie, Inc. | Cell culture methods to reduce acidic species |
| US9249182B2 (en) | 2012-05-24 | 2016-02-02 | Abbvie, Inc. | Purification of antibodies using hydrophobic interaction chromatography |
| US9512214B2 (en) | 2012-09-02 | 2016-12-06 | Abbvie, Inc. | Methods to control protein heterogeneity |
| HK1211981A1 (en) | 2012-09-02 | 2016-06-03 | Abbvie Inc. | Methods to control protein heterogeneity |
| SG11201507230PA (en) | 2013-03-12 | 2015-10-29 | Abbvie Inc | Human antibodies that bind human tnf-alpha and methods of preparing the same |
| WO2014151878A2 (en) | 2013-03-14 | 2014-09-25 | Abbvie Inc. | Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosacharides |
| WO2014159579A1 (en) | 2013-03-14 | 2014-10-02 | Abbvie Inc. | MUTATED ANTI-TNFα ANTIBODIES AND METHODS OF THEIR USE |
| US9017687B1 (en) | 2013-10-18 | 2015-04-28 | Abbvie, Inc. | Low acidic species compositions and methods for producing and using the same using displacement chromatography |
| WO2014170866A2 (en) * | 2013-04-18 | 2014-10-23 | Dr. Reddy's Laboratories Limited | Process of obtaining glycoprotein composition with increased galactosylation content |
| US9598667B2 (en) | 2013-10-04 | 2017-03-21 | Abbvie Inc. | Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins |
| US8946395B1 (en) | 2013-10-18 | 2015-02-03 | Abbvie Inc. | Purification of proteins using hydrophobic interaction chromatography |
| US9085618B2 (en) | 2013-10-18 | 2015-07-21 | Abbvie, Inc. | Low acidic species compositions and methods for producing and using the same |
| US9181337B2 (en) | 2013-10-18 | 2015-11-10 | Abbvie, Inc. | Modulated lysine variant species compositions and methods for producing and using the same |
| US20150139988A1 (en) | 2013-11-15 | 2015-05-21 | Abbvie, Inc. | Glycoengineered binding protein compositions |
| CA2943667C (en) * | 2014-01-29 | 2022-11-08 | Lg Life Sciences Ltd. | Method for modulating galactosylation of recombinant protein through optimization of culture medium |
| KR101660580B1 (ko) * | 2014-04-02 | 2016-09-28 | 프레스티지 바이오파마 피티이. 엘티디. | 항체의 당 함량 조절을 통한 항체의 제조 방법 |
| JP6652334B2 (ja) | 2014-05-31 | 2020-02-19 | Jcrファーマ株式会社 | ウリジンとn−アセチル−d−マンノサミンとを含有する培地 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1993010260A1 (en) * | 1991-11-21 | 1993-05-27 | The Board Of Trustees Of The Leland Stanford Junior University | Controlling degradation of glycoprotein oligosaccharides by extracellular glycosisases |
| CA2351022A1 (en) * | 1998-11-18 | 2000-05-25 | Neose Technologies, Inc. | Low cost manufacture of oligosaccharides |
| US6949372B2 (en) * | 1999-03-02 | 2005-09-27 | The Johns Hopkins University | Engineering intracellular sialylation pathways |
| AU7647000A (en) * | 1999-08-20 | 2001-03-19 | Basf Plant Science Gmbh | Increasing the polysaccharide content in plants |
-
2001
- 2001-02-07 CA CA002399266A patent/CA2399266A1/en not_active Abandoned
- 2001-02-07 WO PCT/US2001/003945 patent/WO2001059089A2/en not_active Ceased
- 2001-02-07 ES ES01907078T patent/ES2266159T3/es not_active Expired - Lifetime
- 2001-02-07 EP EP01907078A patent/EP1254216B1/de not_active Expired - Lifetime
- 2001-02-07 AU AU34903/01A patent/AU783973B2/en not_active Ceased
- 2001-02-07 JP JP2001558229A patent/JP2003521942A/ja active Pending
- 2001-02-07 AT AT01907078T patent/ATE329018T1/de not_active IP Right Cessation
- 2001-02-07 US US10/182,849 patent/US20030211573A1/en not_active Abandoned
- 2001-02-07 DE DE60120356T patent/DE60120356T2/de not_active Expired - Fee Related
- 2001-02-07 IL IL15113101A patent/IL151131A0/xx unknown
-
2006
- 2006-09-29 US US11/537,583 patent/US20070111284A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| ES2266159T3 (es) | 2007-03-01 |
| IL151131A0 (en) | 2003-04-10 |
| EP1254216A2 (de) | 2002-11-06 |
| US20070111284A1 (en) | 2007-05-17 |
| US20030211573A1 (en) | 2003-11-13 |
| WO2001059089A3 (en) | 2002-07-04 |
| DE60120356T2 (de) | 2007-06-14 |
| CA2399266A1 (en) | 2001-08-16 |
| DE60120356D1 (de) | 2006-07-20 |
| EP1254216B1 (de) | 2006-06-07 |
| WO2001059089A2 (en) | 2001-08-16 |
| JP2003521942A (ja) | 2003-07-22 |
| AU783973B2 (en) | 2006-01-12 |
| AU3490301A (en) | 2001-08-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60120356D1 (de) | Verbesserte galactosylierung von rekombinanten proteinen | |
| NO2017028I1 (no) | eftrenonacog alfa eller et biotilsvarende legemiddel ihht Artikkel 10(4) av Directive 2001/83/EC, som beskyttet av basispatentet. | |
| DK1495128T3 (da) | Forstærket proteinekspression i Bacillus | |
| DE69839313D1 (de) | Modifizierte vitamin k-abhängige polypeptide | |
| NO965411D0 (no) | N-terminalt forlengede proteiner uttrykt i gjær | |
| FI971777A0 (fi) | Katepsiini O2-proteaasi | |
| EP1451293A4 (de) | Neue sulfurylase-luciferase-fusionsproteine und temperaturstabile sulfurylase | |
| ATE341627T1 (de) | Als lerk6 bezeichnetes cytokin | |
| ATE490969T1 (de) | Modifizierte transferrin-fusionsproteine | |
| DK1088084T3 (da) | Erythropoietin analog-humant serumalbumin fusionsprotein | |
| DE69929886D1 (de) | Überexpression von phytase in hefesystemen | |
| NO20012718D0 (no) | Ekspresjonssystem for faktor VIII | |
| EP1294513A4 (de) | Lokalisationsspezifische kovalente biokonjugation von proteinen | |
| NO20033673D0 (no) | Fusjonsprotein for sekresjon av et protein av interesse til supernatanten til en bakteriekultur | |
| DE69535696D1 (de) | Tripeptidyl-aminopeptidase | |
| ATE297761T1 (de) | Zubereitungen zur stabilisierung von peg- interferon alpha konjugaten | |
| EP1030557A4 (de) | Proteinproduktion durch expression in sekretorische drüsen | |
| HK1046852A1 (zh) | 用熱震蛋白質令細胞產生更多化學激活素 | |
| EP0676413A3 (de) | Interferon alpha/beta bindendes Protein, seine Herstellung und Anwendung. | |
| DE59009060D1 (de) | Überexpression von Proteinen in rekombinanten Wirtszellen. | |
| GB0119497D0 (en) | Expression of modified antibodies in avian cells | |
| NO20015181D0 (no) | Ekspresjon av heparin-bindende protein i rekombinante pattedyrceller | |
| ATE406446T1 (de) | Vermehrungsproteine von pflanzen | |
| TR199902605T2 (xx) | Fibrinojenin azalt�lma y�ntemleri. | |
| NO20006091D0 (no) | Humant protein C-polypeptid |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1254216 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |